Earnings
ADPT
39.75
+3.52%
1.35
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
123.44M
564.83M
--
10.05M
--
--
0.00
--
14.06M
--
14.54M
--
726.91M
139.04M
--
118.53M
--
118.97M
10.22M
--
2.74M
389.50M
1.12B
--
3.24M
0.00
--
--
--
--
--
26.87M
--
--
--
75.09M
105.20M
0.00
--
--
--
267.95M
267.95M
373.15M
14.00K
1.25B
-511.61M
--
--
--
743.27M
743.27M
1.12B
FY 2019-12-31
96.58M
480.29M
--
12.68M
--
--
0.00
--
9.07M
--
14.08M
--
612.69M
60.35M
--
105.44M
--
118.97M
11.93M
--
2.92M
299.61M
912.30M
--
4.45M
0.00
--
--
--
--
--
10.43M
--
--
--
63.43M
78.31M
36.61M
--
--
--
226.34M
262.95M
341.26M
12.00K
935.83M
-365.48M
--
--
--
571.04M
571.04M
912.30M
FY 2018-12-31
55.03M
109.99M
--
4.81M
--
--
0.00
--
7.84M
--
3.06M
--
180.72M
19.13M
--
0.00
--
118.97M
13.63M
--
247.00K
151.97M
332.69M
--
1.79M
0.00
--
--
--
--
--
7.20M
--
--
--
13.80M
22.80M
336.00K
--
--
--
6.81M
7.14M
29.94M
1000.00
37.90M
-295.91M
--
--
--
302.75M
-258.11M
332.69M
FY 2017-12-31
85.31M
106.84M
--
5.58M
--
--
0.00
--
4.79M
--
2.72M
--
205.25M
13.95M
--
8.90M
--
118.97M
15.32M
--
86.00K
157.24M
362.49M
--
1.96M
0.00
--
--
--
--
--
4.11M
--
--
--
14.93M
21.00M
342.00K
--
--
--
4.43M
4.77M
25.77M
1000.00
24.97M
-249.42M
--
--
--
336.72M
336.72M
362.49M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ADPT latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Adaptive Biotechnologies recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.